Literature DB >> 23105487

Homocysteine status and acute myocardial infarction among Tamilians.

T Angeline1, Rita Mary Aruna, K Ramadevi, G Mohan, Nirmala Jeyaraj.   

Abstract

Myocardial infarction is a major consequence of coronary artery disease. Apart from the traditional risk factors of myocardial infarction, recently many reports have suggested that hyperhomocysteinemia plays important role in myocardial infarction. Plasma homocysteine level was determined in 60 myocardial infarction patients and in 35 age matched healthy individuals. Statistically significant differences (p<0.01) were observed in the mean of plasma homocysteine concentrations between the acute myocardial infarction patients (24.59±6.14 mM/L) and in normal healthy individuals (13.73 ±3.54 mM/L). The level of homocysteine in myocardial infarction patients is significantly high (p <0.01) among myocardial infarction patients when compared to that of the controls. The the present study indicates a strong association between plasma homocysteine and acute myocardial infarction among Tamilians, thus implying plasma homocysteine as a possible risk factor for myocardial infarction.

Entities:  

Keywords:  Acute myocardial infarction; Hyperhomocysteinemia; Proaggregant

Year:  2005        PMID: 23105487      PMCID: PMC3454154          DOI: 10.1007/BF02893035

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  10 in total

1.  Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.

Authors:  J C Chambers; O A Obeid; H Refsum; P Ueland; D Hackett; J Hooper; R M Turner; S G Thompson; J S Kooner
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

2.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

Authors:  M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

Review 3.  Total homocysteine in plasma or serum: methods and clinical applications.

Authors:  P M Ueland; H Refsum; S P Stabler; M R Malinow; A Andersson; R H Allen
Journal:  Clin Chem       Date:  1993-09       Impact factor: 8.327

4.  Absence of association between serum homocysteine levels and coronary artery disease in south Indian males.

Authors:  R Deepa; K Velmurugan; G Saravanan; K Karkuzhali; V Dwarakanath; V Mohan
Journal:  Indian Heart J       Date:  2001 Jan-Feb

5.  Elevation of plasma homocysteine levels associated with acute myocardial infarction.

Authors:  M P Senaratne; J Griffiths; J Nagendran
Journal:  Clin Invest Med       Date:  2000-08       Impact factor: 0.825

6.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

7.  Homocysteine, a Risk Factor for Cardiovascular Disease.

Authors: 
Journal:  Int J Angiol       Date:  1999-01

8.  Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.

Authors:  K G Nair; S R Nair; T F Ashavaid; J J Dalal; F F Eghlim
Journal:  J Assoc Physicians India       Date:  2002-05

9.  Plasma homocysteine levels in patients with coronary heart disease.

Authors:  K A Chacko
Journal:  Indian Heart J       Date:  1998 May-Jun

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

  10 in total
  4 in total

1.  Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease.

Authors:  Rajni R Shivkar; Gayatri C Gawade; Meghana K Padwal; Arundhati G Diwan; Sumiran A Mahajan; Charushila Y Kadam
Journal:  Indian J Clin Biochem       Date:  2021-05-18

2.  MTHFR (Ala 222 Val) polymorphism and AMI in patients with type II diabetes mellitus.

Authors:  T Angeline; G Thiruvarutselvi; W Isabel; Rita Mary Aruna; Rama Devi; Nirmala Jeyaraj
Journal:  Indian J Clin Biochem       Date:  2009-07-09

3.  Risk prediction-Homocysteine in Coronary Heart Disease.

Authors:  Rao B Harish; V Govindaraju; C N Manjunath
Journal:  Indian J Clin Biochem       Date:  2007-03

4.  Cardiovascular Risk Prediction by the American Diabetes Association Risk-Assessment Tool and Novel and Traditional Cardiovascular Risk Factors in Young Adults With Type 1 Diabetes.

Authors:  Isabel Inácio; Teresa Azevedo; José Luís Martins; Ana Margarida M Balsa; Rosa Dantas; Márcia Alves; Isabel Albuquerque; Joana Guimarães
Journal:  Cureus       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.